Persistence to statin treatment: A cohort study in Lithuania
Basic & Clinical Pharmacology & Toxicology · 2024
DOI: 10.1111/bcpt.14015 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, 2024. Verfasst von Karina Kirilova und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacyand Pharmacology Center, Institute of Biomedical Science, Faculty of Medicine, Vilnius University, Vilnius, Lithuania. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Cardiovascular Diseases, Drug Monitoring. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Cardiovascular diseases are the main causes of death, and statins can reduce the risk of major vascular events. Lithuania is among the European countries with the highest cardiovascular mortality despite a rapidly increasing use of statins. Previous reviews have shown the problem of poor patient adherence, but there are limited studies from Eastern European countries. The aim of this study was to evaluate treatment persistence in new users of statins in Lithuania and to investigate factors associated with persistence. Dispensed prescriptions from patients aged >18 years old initiated on statins in 2018–2019 were included, and data were obtained from a national health insurance fund. Persistence was assessed by the proportion of patients who still had statins dispensed 1 year after the first dispensing. Factors associated with persistence were assessed using logistic regression. A total of 104 726 patients (41.3% men) were initiated on statin treatment. Only 41% of them continued statin use 1 year after initiation. Factors associated with higher persistence rate were older age, higher dose of statin, use of other medicines and use of statins as secondary prevention. Low persistence to statin therapy needs to be recognized by healthcare workers, pharmacists and policy makers to address this problem.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmacyand Pharmacology Center, Institute of Biomedical Science, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
- Unit of PharmacoTherapy, Epidemiology & Economics, Groningen Research Institute of Pharmacy, Faculty of Science and Engineering, University of Groningen, Groningen, Netherlands.
- Department of Mathematical Statistics, Faculty of Fundamental Sciences, Vilnius Tech, Vilnius, Lithuania.
- Department of Human and Medical Genetics, Institute of Biomedical Science, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
- Department of Pharmacy, Faculty of Pharmacy, Uppsala University, Uppsala, Sweden.
ORCID-Profile: Indrė Trečiokienė, Björn Wettermark
Zitieren
APA
Kirilova, K., Trečiokienė, I., Bratčikovienė, N., Qvarnström, M., & Wettermark, B. (2024). Persistence to statin treatment: A cohort study in Lithuania. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.14015
Vancouver
Kirilova K, Trečiokienė I, Bratčikovienė N, Qvarnström M, Wettermark B. Persistence to statin treatment: A cohort study in Lithuania. Basic & Clinical Pharmacology & Toxicology. 2024. doi:10.1111/bcpt.14015
BibTeX
@article{Kirilova2024,
author = {Kirilova, Karina and Trečiokienė, Indrė and Bratčikovienė, Nomeda and Qvarnström, Miriam and Wettermark, Björn},
title = {Persistence to statin treatment: A cohort study in Lithuania},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2024},
doi = {10.1111/bcpt.14015}
}
EUVIMED